A detailed history of Eastern Bank transactions in Dexcom Inc stock. As of the latest transaction made, Eastern Bank holds 136 shares of DXCM stock, worth $10,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136
Previous 4,590 97.04%
Holding current value
$10,372
Previous $520,000 98.27%
% of portfolio
0.0%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$64.0 - $116.06 $285,056 - $516,931
-4,454 Reduced 97.04%
136 $9,000
Q4 2023

Jan 25, 2024

BUY
$75.49 - $124.16 $56,617 - $93,120
750 Added 19.53%
4,590 $569,000
Q2 2022

Jul 20, 2022

BUY
$67.99 - $132.89 $195,811 - $382,723
2,880 Added 300.0%
3,840 $286,000
Q1 2022

Apr 21, 2022

BUY
$94.08 - $130.2 $90,316 - $124,991
960 New
960 $491,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Eastern Bank Portfolio

Follow Eastern Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.